Document ID: chunk:federal_register_of_legislation:F2019L01689:reg:9
Version: federal_register_of_legislation:F2019L01689
Segment Type: reg
Provision Reference: reg 9
Character Range: 3674–5824

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting Kaposi sarcoma or death from Kaposi sarcoma with the circumstances of a person's relevant service:
(1)          having infection with human herpesvirus type 8 before the clinical onset of Kaposi sarcoma;
(2)          having infection with human immunodeficiency virus before the clinical onset of Kaposi sarcoma;
(3)          having non-Hodgkin lymphoma or chronic lymphocytic leukaemia/small lymphocytic lymphoma before the clinical onset of Kaposi sarcoma;
(4)          having chronic renal failure at least six months before the clinical onset of Kaposi sarcoma;
Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(5)          having an autoimmune disease from the specified list of autoimmune diseases at least six months before the clinical onset of Kaposi sarcoma;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(6)          having diabetes mellitus for at least six months before the clinical onset of Kaposi sarcoma;
(7)          having lymphoedema involving the affected site at least five years before the clinical onset of Kaposi sarcoma;
(8)          undergoing solid organ, stem cell or bone marrow transplantation before the clinical onset of Kaposi sarcoma;
(9)          being treated with an immunosuppressive drug:
(a)          for a continuous period of at least three months before the clinical onset of Kaposi sarcoma; and
(b)          where that exposure has ceased, the clinical onset of Kaposi sarcoma has occurred within ten years of cessation;
Note: immunosuppressive drug is defined in the Schedule 1 - Dictionary.
(10)      being treated with an angiotensin converting enzyme inhibitor:
(a)          for at least three months before the clinical onset of Kaposi sarcoma; and
(b)          where that exposure has ceased, the clinical onset of Kaposi sarcoma has occurred within ten years of cessation;
(11)      inability to obtain appropriate clinical management for Kaposi sarcoma.